Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China flag China · Delayed Price · Currency is CNY
21.88
+0.34 (1.58%)
Feb 3, 2026, 3:00 PM CST

SHA:600285 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
459.661,2281,4991,179801.24732.32
Short-Term Investments
574.05283.0195.63125.34140.7740.08
Trading Asset Securities
325.72-0.21150.42280.1957.23
Cash & Short-Term Investments
1,3591,5111,5951,4551,222829.63
Cash Growth
42.08%-5.23%9.60%19.05%47.32%7.88%
Accounts Receivable
773.86488.95498.99511.97431.18708.6
Other Receivables
9.916.2919.3521.379.588.54
Receivables
783.77495.23518.34533.34440.77717.13
Inventory
407.28434.97467.35486.41428.39331.41
Prepaid Expenses
-----0.38
Other Current Assets
23.6316.4518.5133.5839.8737.98
Total Current Assets
2,5742,4582,5992,5082,1311,917
Property, Plant & Equipment
697.97631.2647.81706.76732.92730.03
Long-Term Investments
268.531,4371,069676.63364.7349.75
Goodwill
482.02-----
Other Intangible Assets
337.94203.75202.5203.65236.95235.04
Long-Term Deferred Tax Assets
218.78199.59186.92159.2116.4997.79
Long-Term Deferred Charges
14.7312.3436.7351.5465.5387.15
Other Long-Term Assets
1,16274.4529.9838.45145.2541.45
Total Assets
5,7565,0174,7724,3453,7933,458
Accounts Payable
91.7785.1357.3868.0278.0178.81
Accrued Expenses
149.451,1761,110917.79600.38528.26
Short-Term Debt
516.6890.47199.94151.15272.34166
Current Portion of Leases
2.841.781.081.221.65-
Current Income Taxes Payable
148.7656.2870.7255.5446.952.46
Current Unearned Revenue
46.92114.28114.48153.7579.0971.73
Other Current Liabilities
1,437350.24346.95364.47359.28169.01
Total Current Liabilities
2,3941,8741,9001,7121,4381,066
Long-Term Leases
5.566.556.966.27.9-
Long-Term Unearned Revenue
29.4133.439.7838.5542.7848.26
Long-Term Deferred Tax Liabilities
43.922.2726.3229.5618.1821.09
Total Liabilities
2,4721,9371,9731,7861,5071,136
Common Stock
567.12567.12567.14567.46567.76567.81
Additional Paid-In Capital
360.59340.61326.23309.82272.02319.63
Retained Earnings
2,3302,1811,8941,6641,4811,340
Treasury Stock
-12.58-13.7-47.4-67.62-98.19-
Comprehensive Income & Other
2.85-2.025176.7456.0884.87
Total Common Equity
3,2483,0732,7912,5512,2792,313
Minority Interest
35.057.777.667.557.599.43
Shareholders' Equity
3,2833,0802,7992,5582,2872,322
Total Liabilities & Equity
5,7565,0174,7724,3453,7933,458
Total Debt
525.0898.8207.99158.57281.89166
Net Cash (Debt)
834.351,4131,3871,296940.31663.63
Net Cash Growth
-10.81%1.86%6.96%37.88%41.69%35.98%
Net Cash Per Share
1.462.502.452.281.661.17
Filing Date Shares Outstanding
566.15564.42563.94569.61564.55562.16
Total Common Shares Outstanding
566.15564.42563.94569.61564.55567.81
Working Capital
180.57583.7698.77796.44693.59850.28
Book Value Per Share
5.745.444.954.484.044.07
Tangible Book Value
2,4282,8692,5892,3472,0422,078
Tangible Book Value Per Share
4.295.084.594.123.623.66
Buildings
-588.03593.96595.01582.83577.6
Machinery
-591.9581.63581.92534.7511.65
Construction In Progress
-34.22.881.9224.782.78
Source: S&P Global Market Intelligence. Standard template. Financial Sources.